Nicholas Landekic is a Founder of PolyMedix and has served as President, Chief Executive Officer and Director since inception in 2002. Under his leadership, PolyMedix has internally built a pipeline of cardiovascular and infectious disease drugs, with lead candidates from each program in Phase 2 clinical trials. Since starting PolyMedix, Mr. Landekic has successfully secured over $115 million in funding from public and private capital raises and government contracts and grants. For the past 25 years, Mr. Landekic has held leadership positions in business development, marketing, and finance with biotechnology and pharmaceutical companies. Prior to PolyMedix, Mr. Landekic was President and Chief Executive Officer of Locus Discovery, and also held positions in Corporate/Business Development, Strategic Marketing, and Finance at Guilford Pharmaceuticals, Cephalon, Bristol-Myers Squibb and Johnson & Johnson Corporation (McNeil Pharmaceutical). Earlier in his career, he worked in the research laboratories at Mt. Sinai Medical Center. Mr. Landekic received an MBA from the State University of New York at Albany, an M.A. in Biology from Indiana University and a B.S. in Biology from Marist College.